Product Details

Verified Reactivity

Human

Antibody Type

Monoclonal

Host Species

Mouse

Formulation

Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).

Preparation

The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 650? under optimal conditions.

Concentration

Lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)

Storage & Handling

The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.

Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood.

Brilliant Violet 650? excites at 405 nm and emits at 645 nm. The bandpass filter 660/20 nm is recommended for detection, although filter optimization may be required depending on other fluorophores used. Be sure to verify that your cytometer configuration and software setup are appropriate for detecting this channel. Refer to your instrument manual or manufacturer for support. Brilliant Violet 650? is a trademark of Sirigen Group Ltd.

Learn more about Brilliant Violet?.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.

Excitation Laser

Violet Laser (405 nm)

Application Notes

The OKT3 monoclonal antibody reacts with an epitope on the epsilon-subunit within the human CD3 complex.

Clone OKT3 can block the binding of clones SK7 and UCHT1.⁴ The OKT3 antibody is able to induce T cell activation. Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen sections and activation of T cells. The LEAF? purified antibody (Endotoxin <0.1 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays (Cat. No. 317304). For highly sensitive assays, we recommend Ultra-LEAF? purified antibody (Cat. No. 317326) with a lower endotoxin limit than standard LEAF? purified antibodies (Endotoxin <0.01 EU/?g).

Application References

(PubMed link indicates BioLegend citation)

1. Schlossman S, et al. Eds. 1995. Leucocyte Typing V. Oxford University Press. New York.
2. Knapp W. 1989. Leucocyte Typing IV. Oxford University Press New York.
3. Barclay N, et al. 1997. The Leucocyte Antigen Facts Book. Academic Press Inc. San Diego.
4. Li B, et al. 2005. Immunology 116:487.
5. Jeong HY, et al. 2008. J. Leuckocyte Biol. 83:755. PubMed
6. Alter G, et al. 2008. J. Virol. 82:9668. PubMed
7. Manevich-Mendelson E, et al. 2009. Blood 114:2344. PubMed
8. Pinto JP, et al. 2010. Immunology. 130:217. PubMed
9. Biggs MJ, et al. 2011. J. R. Soc. Interface. 8:1462. PubMed

Product Citations

1. Lucera M, et al. 2014. J Virol. 88:10803. PubMed
2. Savage TM, et al. 2018. JCI Insight. 3:. PubMed
3. Riou C, et al. 2014. PLoS One. 9:102178. PubMed
4. Xu Y, et al. 2015. J Vis Exp. 99: 52863. PubMed
5. Boyle M, et al. 2015. PLoS Pathog. 11: 1005041. PubMed
6. Booth JS, et al. 2019. Hum Vaccin Immunother. :1. PubMed
7. Boyle M, et al. 2015. J Infect Dis. 212: 416-425. PubMed
8. Naaber P, et al. 2022. Cell Rep Med. 3:100716. PubMed
9. Rodda LB, et al. 2020. Cell. 184(1):169-183.e17. PubMed
10. Mikulak J, et al. 2019. JCI Insight. 4:e125884. PubMed
11. Tilton C, et al. 2013. J Virol Methods. 166:376. PubMed
12. Lu Y, et al. 2021. Gastroenterology. 161:575. PubMed
13. Keeton R, et al. 2021. Cell Host Microbe. 29:1611. PubMed
14. Vardam-Kaur T, et al. 2021. Oncotarget. 12:2051. PubMed
15. Bradley T et al. 2018. Cell. 175(2):387-399 . PubMed
16. Hardman CS, et al. 2021. Sci Immunol. 6:. PubMed
17. Ni J, et al. 2020. Immunity. 52(6):1075-1087.e8. PubMed
18. Poon MML, et al. 2021. Cell Rep. 37:110071. PubMed
19. Escudero–Pérez B, et al. 2019. JCI Insight. 4:e126070. PubMed
20. Khosravi-Maharlooei M, et al. 2021. J Autoimmun. 119:102612. PubMed
21. Franco LM, et al. 2019. J Exp Med. 216:384. PubMed
22. Waight JD, et al. 2018. Cancer Cell. 33:1033. PubMed
23. Khuzwayo S, et al. 2021. Front Immunol. 12:631410. PubMed
24. Boudreau J, et al. 2014. PLoS One. 9:99543. PubMed
25. Shuwa HA, et al. 2021. Med. 2(6):720-735.e4. PubMed
26. Mattiola I, et al. 2015. J Immunol. 195: 2818-2828. PubMed
27. Lee J, et al. 2015. J Exp Med. 212:385. PubMed
28. Querfeld C, et al. 2018. Cancer Immunol Res. 6:900. PubMed
29. Breton G, et al. 2015. J Exp Med. 212:401. PubMed
30. Pierce CA, et al. 2020. Sci Transl Med. 12:00. PubMed
31. Robert R, et al. 2017. PLoS One. 10.1371/journal.pone.0184278. PubMed
32. Clayton KL, et al. 2021. Cell Host Microbe. 29(3):435-447.e9. PubMed
33. Salumets A, et al. 2022. Aging Cell. 21:e13607. PubMed
34. Garfall AL, et al. 2018. JCI Insight. 3. PubMed

RRID

AB_11126748 (BioLegend Cat. No. 317323) AB_2563352 (BioLegend Cat. No. 317324)